Rational Design of Stable Protein Formulations: Theory and Practice
Recombinant proteins and polypeptides continue to be the most important class of biotechnology-derived agents in today's pharmaceutical industry. Over the past few years, our fundamental understanding of how proteins degrade and how stabilizing agents work has made it possible to approach formu...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
2002
|
| Schriftenreihe: | Pharmaceutical Biotechnology
13 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | Recombinant proteins and polypeptides continue to be the most important class of biotechnology-derived agents in today's pharmaceutical industry. Over the past few years, our fundamental understanding of how proteins degrade and how stabilizing agents work has made it possible to approach formulation of protein pharmaceuticals from a much more rational point of view. This book describes the current level of understanding of protein instability and the strategies for stabilizing proteins under a variety of stressful conditions |
| Beschreibung: | 1 Online-Ressource (XVII, 206 p) |
| ISBN: | 9781461505570 |
| DOI: | 10.1007/978-1-4615-0557-0 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046148481 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190906s2002 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461505570 |9 978-1-4615-0557-0 | ||
| 024 | 7 | |a 10.1007/978-1-4615-0557-0 |2 doi | |
| 035 | |a (ZDB-2-SBL)978-1-4615-0557-0 | ||
| 035 | |a (OCoLC)1119002669 | ||
| 035 | |a (DE-599)BVBBV046148481 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 615 |2 23 | |
| 245 | 1 | 0 | |a Rational Design of Stable Protein Formulations |b Theory and Practice |c edited by John F. Carpenter, Mark C. Manning |
| 264 | 1 | |a Boston, MA |b Springer US |c 2002 | |
| 300 | |a 1 Online-Ressource (XVII, 206 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Pharmaceutical Biotechnology |v 13 | |
| 520 | |a Recombinant proteins and polypeptides continue to be the most important class of biotechnology-derived agents in today's pharmaceutical industry. Over the past few years, our fundamental understanding of how proteins degrade and how stabilizing agents work has made it possible to approach formulation of protein pharmaceuticals from a much more rational point of view. This book describes the current level of understanding of protein instability and the strategies for stabilizing proteins under a variety of stressful conditions | ||
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Pharmacy | |
| 650 | 4 | |a Biochemistry, general | |
| 650 | 4 | |a Biotechnology | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Pharmacy | |
| 650 | 4 | |a Biochemistry | |
| 650 | 4 | |a Biotechnology | |
| 700 | 1 | |a Carpenter, John F. |4 edt | |
| 700 | 1 | |a Manning, Mark C. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461351313 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306467417 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461505587 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4615-0557-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 940 | 1 | |q ZDB-2-SBL_2000/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031528658 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4615-0557-0 |l UBR01 |p ZDB-2-SBL |q ZDB-2-SBL_2000/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180488806465536 |
|---|---|
| any_adam_object | |
| author2 | Carpenter, John F. Manning, Mark C. |
| author2_role | edt edt |
| author2_variant | j f c jf jfc m c m mc mcm |
| author_facet | Carpenter, John F. Manning, Mark C. |
| building | Verbundindex |
| bvnumber | BV046148481 |
| collection | ZDB-2-SBL |
| ctrlnum | (ZDB-2-SBL)978-1-4615-0557-0 (OCoLC)1119002669 (DE-599)BVBBV046148481 |
| dewey-full | 615 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615 |
| dewey-search | 615 |
| dewey-sort | 3615 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4615-0557-0 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02260nmm a2200505zcb4500</leader><controlfield tag="001">BV046148481</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190906s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461505570</subfield><subfield code="9">978-1-4615-0557-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4615-0557-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBL)978-1-4615-0557-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119002669</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046148481</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rational Design of Stable Protein Formulations</subfield><subfield code="b">Theory and Practice</subfield><subfield code="c">edited by John F. Carpenter, Mark C. Manning</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVII, 206 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmaceutical Biotechnology</subfield><subfield code="v">13</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Recombinant proteins and polypeptides continue to be the most important class of biotechnology-derived agents in today's pharmaceutical industry. Over the past few years, our fundamental understanding of how proteins degrade and how stabilizing agents work has made it possible to approach formulation of protein pharmaceuticals from a much more rational point of view. This book describes the current level of understanding of protein instability and the strategies for stabilizing proteins under a variety of stressful conditions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carpenter, John F.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manning, Mark C.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461351313</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306467417</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461505587</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4615-0557-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2000/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031528658</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4615-0557-0</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">ZDB-2-SBL_2000/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046148481 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:34Z |
| institution | BVB |
| isbn | 9781461505570 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031528658 |
| oclc_num | 1119002669 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XVII, 206 p) |
| psigel | ZDB-2-SBL ZDB-2-SBL_2000/2004 ZDB-2-SBL ZDB-2-SBL_2000/2004 |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Springer US |
| record_format | marc |
| series2 | Pharmaceutical Biotechnology |
| spelling | Rational Design of Stable Protein Formulations Theory and Practice edited by John F. Carpenter, Mark C. Manning Boston, MA Springer US 2002 1 Online-Ressource (XVII, 206 p) txt rdacontent c rdamedia cr rdacarrier Pharmaceutical Biotechnology 13 Recombinant proteins and polypeptides continue to be the most important class of biotechnology-derived agents in today's pharmaceutical industry. Over the past few years, our fundamental understanding of how proteins degrade and how stabilizing agents work has made it possible to approach formulation of protein pharmaceuticals from a much more rational point of view. This book describes the current level of understanding of protein instability and the strategies for stabilizing proteins under a variety of stressful conditions Pharmacology/Toxicology Pharmacy Biochemistry, general Biotechnology Toxicology Biochemistry Carpenter, John F. edt Manning, Mark C. edt Erscheint auch als Druck-Ausgabe 9781461351313 Erscheint auch als Druck-Ausgabe 9780306467417 Erscheint auch als Druck-Ausgabe 9781461505587 https://doi.org/10.1007/978-1-4615-0557-0 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Rational Design of Stable Protein Formulations Theory and Practice Pharmacology/Toxicology Pharmacy Biochemistry, general Biotechnology Toxicology Biochemistry |
| title | Rational Design of Stable Protein Formulations Theory and Practice |
| title_auth | Rational Design of Stable Protein Formulations Theory and Practice |
| title_exact_search | Rational Design of Stable Protein Formulations Theory and Practice |
| title_full | Rational Design of Stable Protein Formulations Theory and Practice edited by John F. Carpenter, Mark C. Manning |
| title_fullStr | Rational Design of Stable Protein Formulations Theory and Practice edited by John F. Carpenter, Mark C. Manning |
| title_full_unstemmed | Rational Design of Stable Protein Formulations Theory and Practice edited by John F. Carpenter, Mark C. Manning |
| title_short | Rational Design of Stable Protein Formulations |
| title_sort | rational design of stable protein formulations theory and practice |
| title_sub | Theory and Practice |
| topic | Pharmacology/Toxicology Pharmacy Biochemistry, general Biotechnology Toxicology Biochemistry |
| topic_facet | Pharmacology/Toxicology Pharmacy Biochemistry, general Biotechnology Toxicology Biochemistry |
| url | https://doi.org/10.1007/978-1-4615-0557-0 |
| work_keys_str_mv | AT carpenterjohnf rationaldesignofstableproteinformulationstheoryandpractice AT manningmarkc rationaldesignofstableproteinformulationstheoryandpractice |